Literature DB >> 31462094

Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Yabing Chen1,2, Xinyang Zhao3, Hui Wu4.   

Abstract

Mammalian cells metabolize glucose primarily for energy production, biomass synthesis, and posttranslational glycosylation; and maintaining glucose metabolic homeostasis is essential for normal physiology of cells. Impaired glucose homeostasis leads to hyperglycemia, a hallmark of diabetes mellitus. Chronically increased glucose in diabetes mellitus promotes pathological changes accompanied by impaired cellular function and tissue damage, which facilitates the development of cardiovascular complications, the major cause of morbidity and mortality of patients with diabetes mellitus. Emerging roles of glucose metabolism via the hexosamine biosynthesis pathway (HBP) and increased protein modification via O-linked β-N-acetylglucosamine (O-GlcNAcylation) have been demonstrated in diabetes mellitus and implicated in the development of diabetic cardiovascular complications. This review will discuss the biological outcomes of the glucose metabolism via the hexosamine biogenesis pathway and protein O-GlcNAcylation in regulating cellular homeostasis, and highlight the regulations and contributions of elevated O-GlcNAcylation to the pathogenesis of diabetic cardiovascular disease.

Entities:  

Keywords:  acetylglucosamine; cardiovascular disease; diabetes mellitus; hexosamines; hyperglycemia

Year:  2019        PMID: 31462094      PMCID: PMC6761006          DOI: 10.1161/ATVBAHA.119.312192

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  140 in total

Review 1.  The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.

Authors:  P King; I Peacock; R Donnelly
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 2.  Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.

Authors:  L Wells; K Vosseller; G W Hart
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

3.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.

Authors:  T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

4.  Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats.

Authors:  L K Kreppel; G W Hart
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

5.  Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes.

Authors:  G Boden; X Chen; M Polansky
Journal:  Diabetes       Date:  1999-11       Impact factor: 9.461

6.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation.

Authors:  X L Du; D Edelstein; L Rossetti; I G Fantus; H Goldberg; F Ziyadeh; J Wu; M Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

7.  O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.

Authors:  X Yang; K Su; M D Roos; Q Chang; A J Paterson; J E Kudlow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

8.  Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death.

Authors:  K Liu; A J Paterson; E Chin; J E Kudlow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

9.  Increased O-GlcNAc transferase in pancreas of rats with streptozotocin-induced diabetes.

Authors:  Y Akimoto; L K Kreppel; H Hirano; G W Hart
Journal:  Diabetologia       Date:  2000-10       Impact factor: 10.122

10.  Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase.

Authors:  N Comtesse; E Maldener; E Meese
Journal:  Biochem Biophys Res Commun       Date:  2001-05-11       Impact factor: 3.575

View more
  14 in total

Review 1.  Vascular Metabolic Mechanisms of Pulmonary Hypertension.

Authors:  Xiao-Fan Shi; Yun-Chao Su
Journal:  Curr Med Sci       Date:  2020-07-17

Review 2.  Posttranslational modifications in diabetes: Mechanisms and functions.

Authors:  Bin Chen; Jianing Zhong; Ang Hu; Haohong Zou
Journal:  Rev Endocr Metab Disord       Date:  2022-06-13       Impact factor: 9.306

3.  Precision Mapping of O-Linked N-Acetylglucosamine Sites in Proteins Using Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Edwin E Escobar; Dustin T King; Jesús E Serrano-Negrón; Matthew G Alteen; David J Vocadlo; Jennifer S Brodbelt
Journal:  J Am Chem Soc       Date:  2020-06-19       Impact factor: 15.419

Review 4.  Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-02       Impact factor: 8.311

Review 5.  O-GlcNAcylation: the "stress and nutrition receptor" in cell stress response.

Authors:  Rui-Zhi Yao; Yang Liu; Shuai Lian; Peng Liu; Ya-Jie Hu; Hong-Zhao Shi; Hong-Ming Lv; Yu-Ying Yang; Bin Xu; Shi-Ze Li
Journal:  Cell Stress Chaperones       Date:  2020-11-07       Impact factor: 3.667

6.  Glucose regulates tissue-specific chondro-osteogenic differentiation of human cartilage endplate stem cells via O-GlcNAcylation of Sox9 and Runx2.

Authors:  Chao Sun; Weiren Lan; Bin Li; Rui Zuo; Hui Xing; Minghan Liu; Jie Li; Yuan Yao; Junlong Wu; Yu Tang; Huan Liu; Yue Zhou
Journal:  Stem Cell Res Ther       Date:  2019-11-28       Impact factor: 6.832

Review 7.  Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I.

Authors:  Raquel Vieira; Selma B Souto; Elena Sánchez-López; Ana López Machado; Patricia Severino; Sajan Jose; Antonello Santini; Ana Fortuna; Maria Luisa García; Amelia M Silva; Eliana B Souto
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-10

Review 8.  Transcriptional Programming in Arteriosclerotic Disease: A Multifaceted Function of the Runx2 (Runt-Related Transcription Factor 2).

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

Review 9.  O-GlcNAcylation in Hyperglycemic Pregnancies: Impact on Placental Function.

Authors:  Jie Ning; Huixia Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

10.  OGT-Mediated KEAP1 Glycosylation Accelerates NRF2 Degradation Leading to High Phosphate-Induced Vascular Calcification in Chronic Kidney Disease.

Authors:  Tian-Hua Xu; Yinke Du; Zitong Sheng; Yue Li; Xiaobo Qiu; Binyao Tian; Li Yao
Journal:  Front Physiol       Date:  2020-10-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.